CFC-Containing Asthma Inhalers May Not Be Reformulated If Little Used - FDA
Executive Summary
Some currently-available asthma inhalers may never be reformulated in non-CFC versions, FDA Pulmonary Drug Products Division Director John Jenkins acknowledged during a House Commerce/Health Subcommittee hearing on FDA's transition plan for chlorofluorocarbon-based asthma inhalers May 6.